







































Recommendations  for  interventional  pulmonology
during COVID-19  outbreak:  a consensus  statement
from the Portuguese  Pulmonology  Society
F. Guedesa,b,c,∗, J.P. Boléo-Toméd, L.V. Rodriguese,f, H.N. Bastosg,h,i, S. Campainhaj,
M. de Santisk, L. Mota l, A. Bugalhom,n
a Centro  Hospitalar  do  Porto  (CHP),  Hospital  Geral  de  Santo  António  (HGSA),  Unidade  de  Broncologia,  Serviço  de  Pneumologia,
Porto, Portugal
b Departamento  de  Clínicas  Veterinárias,  Instituto  de  Ciências  Biomédicas  de  Abel  Salazar  (ICBAS),  Universidade  do  Porto  (UP),
Porto, Portugal
c Centro  de  Estudos  de  Ciência  Animal  (CECA),  Instituto  de  Ciências,  Tecnologias  e  Agroambiente  (ICETA)  da  Universidade  do
Porto, Praça Gomes  Teixeira,  Apartado  55142,  4051-401,  Porto,  Portugal
d Pulmonology  Department,  Hospital  Prof.  Doutor  Fernando  Fonseca,  Amadora,  Portugal
e Pulmonology  Department,  Hospital  Sousa  Martins,  Unidade  Local  de  Saúde  da  Guarda,  Guarda,  Portugal
f Faculty  of  Health  Sciences,  University  of  Beira  Interior,  Covilhã,  Portugal
g Department  of  Pneumology,  Centro  Hospitalar  São  João,  Porto,  Portugal
h Faculty  of  Medicine,  University  of  Porto,  Porto,  Portugal
i IBMC/i3S  -  Instituto  de  Biologia  Molecular  e  Celular  /  Instituto  de  Investigação  e  Inovação  em  Saúde,  University  of  Porto,
Portugal
j Pulmonology  Department,  Vila  Nova  de  Gaia-Espinho  Hospital  Center,  Vila  Nova  de  Gaia,  Portugal
k Pulmonology  Department,  Instituto  Português  de  Oncologia  (IPO),  Coimbra,  Portugal
l Pulmonology  Department,  Hospital  Pulido  Valente,  Centro  Hospitalar  Lisboa  Norte,  Lisboa,  Portugal
m Pulmonology  Department,  CUF  Infante  Santo  Hospital  and  CUF  Descobertas  Hospital,  Lisbon,  Portugal
n Comprehensive  Health  Research  Centre,  Chronic  Diseases  Research  Center  (CEDOC),  NOVA  Medical  School,  Lisbon,  Portugal





Abstract  Coronavirus  disease  2019  (COVID-19)  is  an  emerging  infectious  disease  caused  by  a
novel SARS-CoV-2  pathogen.  Its  capacity  for  human-to-human  transmission  through  respiratory
droplets,  coupled  with  a  high-level  of  population  mobility,  has  resulted  in  a  rapid  dissemination
worldwide.  Healthcare  workers  have  been  particularly  exposed  to  the  risk  of  infection  andortion  of  COVID-19  cases  in  the  worst  affected  regions  of  Europe.
procedures  or  aerosol-generating  procedures,  bronchoscopy  poses
ing  contaminated  droplets,  and  medical  workers  must  adapt  theThoracocentesis;
COVID-19;
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procedures  to  ensure  safety  of  both  patients  and  staff.  Several  recommendation  documents
were published  at  the  beginning  of  the  pandemic,  but  as  the  situation  evolves,  our  thoughts
should not  only  focus  on  the  present,  but  should  also  reflect  on  how  we  are  going  to  deal  with  the
presence  of  the  virus  in  the  community  until  there  is  a  vaccine  or  specific  treatment  available.
It is  in  this  sense  that  this  document  aims  to  guide  interventional  pulmonology  throughout
this period,  providing  a  set  of  recommendations  on  how  to  perform  bronchoscopy  or  pleural
procedures  safely  and  efficiently.
© 2020  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.U.  This  is  an













































































































































































oronavirus  Disease  2019  (COVID-19),  a  new  infectious
isease  that  emerged  in  early  December  2019  in  Wuhan
China),1 is  triggered  by  a  novel  pathogen  with  phylogenetic
imilarity  to  what  caused  the  severe  acute  respiratory  syn-
rome  (SARS)  outbreak  in  2003,  and  was  called  SARS-CoV-2.2
ts  capacity  for  human-to-human  transmission  and  interna-
ional  air  travel  facilitated  the  rapid  dissemination  on  an
nprecedented  scale  to  the  rest  of  the  world.3,4
In  Italy,  the  latest  figures  reported  that  9%  of  COVID-19
ases  were  health  care  workers  (HCW),  while  in  Spain  the
ate  of  medical  staff  infected  reached  26%,  the  highest  in
urope.5 In  Portugal,  by  12th  May  2020,  11.3%  of  infections
ccurred  in  HCW.6 There  are  at  least  two  explanations  for
uch  a  high  number  of  infected  personnel.  First,  the  lack  of
roper  personal  protective  equipment  (PPE)  at  the  begin-
ing  of  the  epidemic,  when  assisting  both  confirmed  and
uspected  patients  with  COVID-19.  Second,  the  duration  of
xposure  to  infected  patients  undergoing  aerosol-generating
rocedures,  such  as  non-invasive  ventilation  (NIV)  and  bron-
hoscopy,  directly  resulting  in  a  significant  increase  in  the
isk  of  transmission  to  HCW.
The  Portuguese  Society  of  Pulmonology  recently  issued
 set  of  recommendations  for  bronchoscopic  procedures,7
hortly  after  the  diagnosis  of  the  first  cases  in  Portugal.
he  document  aimed  to  guarantee  the  protection  of  both
atients  and  medical  practicioners,  and  to  ensure  that  the
ealthcare  workforce  would  be  conserved  to  fullfill  their
ission  throughout  the  period.  Since  then,  a  significant
mount  of  scientific  evidence  has  been  accumulated;  so,
he  present  document  gives  an  update  of  the  available  lit-
rature,  providing  practical  suggestions  for  pulmonologists
ndergoing  bronchoscopy  or  pleural  procedures  in  the  set-
ing  of  the  current  and  post-pandemic  phases.
isk of  transmission
espiratory  droplets  comprise  the  main  route  of  SARS-
oV-2  transmission,  although  airborne  transmission  is  also
ossible  through  aerosol-generating  procedures,  such  as
ronchoscopy.8 One  study  during  the  H1N1  pandemic  pro-Please  cite  this  article  in  press  as:  Guedes  F,  et  al.  Pulmonol.  2
ided  experimental  evidence  that  bronchoscopic  procedures
ncreases  more  than  4  times  the  viral  copy  number  per  litre
n  positive  air  samples.9 While  the  heavy  droplets  rapidly





re  dispersed  in  the  air  over  extensive  distances,  posing  a
onsiderable  risk  of  infection  in  enclosed  spaces,  specially
f  poorly  ventilated.10
The  contribution  of  asymptomatic  carriers  has  also  been
ubject  of  debate.11,12 A  significant  proportion  of  them
ave  lung  abnormalities  on  chest  CT  scans13,14 and  a  high
evel  of  viral  shedding  may  be  detected  in  presymptomatic
atients,14 so  it  is  likely  that  transmission  occurs  in  the  early
tages  of  infection  when  patients  are  either  minimally  symp-
omatic  or  asymptomatic.  Unrecognized  patients  pose  a  real
hallenge  to  infection  control  and,  when  not  promptly  han-
led  with  appropriate  airborne  precautions,  are  one  of  the
ost  critical  factors  for  SARS-CoV-2  infection  spread  in  the
ealthcare  setting.
ethods
he  Portuguese  Pulmonology  Society  appointed  FG  to  chair
his  consensus  group.  Seven  national  IP  specialists  were
elected  based  on  their  clinical  expertise  and  different
ettings  (university  vs.  non-university  hospitals;  state  vs.
rivate  hospitals;  pulmonologists  vs.  critical  care  special-
sts;  ...).  At  the  first  online  consensus  meeting,  attended
y  all  members,  a  primary  draft  with  several  sections  was
reated.  This  was  shared  online  and  further  improved  by
ritten  comments  and  suggestions.  Then,  each  IP  specialist
as  assigned  a  specific  section  presented  in  this  document
nd  was  responsible  for  reviewing  and  evaluating  the  rel-
vant  available  literature  related  to  the  topic.  Electronic
atabases  (Pubmed,  OVID  Medline  and  Embase,  Web  of  Sci-
nce,  Cochrane  Central  Register  of  Controlled  Trials)  were
sed  to  search  for  the  terms  ‘‘COVID-19’’  OR  ‘‘SARS-CoV-2’’
ND  (‘‘bronchoscopy’’  OR  ‘‘interventional  pulmology’’  OR
‘thoracentesis’’  OR  ‘‘thoracocentesis’’  OR  ‘‘pleural  effu-
ion’’  OR  ‘‘pneumothorax’’  OR  ‘‘rigid  bronchoscopy’’  OR
‘thoracoscopy’’  OR  ‘‘chest  drain’’).  Position  papers  from
ajor  health  organizations  (US  Centers  for  Disease  Con-
rol  and  Prevention,  European  Centre  for  Disease  Prevention
nd  Control  and  World  Health  Organization)  and  important
cientific  societies  (European  Respiratory  Society,  European
ssociation  for  Bronchology  and  Interventional  Pulmonology,PULMOE 1525 1--12020.  https://doi.org/10.1016/j.pulmoe.2020.07.007
merican  Association  for  Bronchology  and  Interventional
ulmonology,  World  Association  for  Bronchology  and  Inter-


































































































































Recommendations  for  interventional  pulmonology  during  CO
In  a  second  online  conference  the  complete  draft  was
evaluted  by  all  team  members  and  two  working  groups  were
created.  They  were  responsible  for  discussing  and  revis-
ing  different  sections,  and  editing  the  text  for  consistency.
Afterwards,  the  final  manuscript  was  distributed  to  the
consensus  group  members  and  assessed  for  final  approval.
Adaptations of the interventional pulmonology
(IP) department
Although  there  is  still  some  heterogeneity  in  the  definition
and  scope  of  of  ‘‘interventional  pulmonology’’  (IP),  it  has
become  the  most  widely  accepted  term  to  describe  the  use
of  techniques  for  the  diagnosis  and  treatment  of  a  growing
number  of  thoracic  disorders.15
In  the  context  of  this  document,  the  term  IP  is  used
to  encompass  the  concepts  of  bronchoscopy  (diagnostic
or  therapeutic),  advanced  bronchoscopy  (flexible  or  rigid
bronchoscopy  and  all  its  associated  techniques),  pleu-
roscopy  (rigid  or  semi-flexible)  and  other  simpler  pleural
techniques  (such  as  thoracentesis,  placement  of  thoracic
drainage  systems  and  indwelling  pleural  catheters).  Though
we  acknowledge  this  wider  definition  of  IP  may  be  contro-
versial,  it  covers  all  technical  domains  that  most  Portuguese
pulmonologists  need  to  address,  and  for  the  purpose  of  this
document,  it  positions  us  to  issue  general  recommendations.
In  the  following  subsections,  specific  scenarios  of  differ-
ent  technical  specializations  will  be  addressed  in  order  to
overcome  this  broader  definition  and  to  apply  it  better  to
individual  settings.
The  IP  department  is  a  high-risk  area,  given  the  type
of  procedures  that  are  performed  with  airway  manipulation
and  with  multiple  staff  involved.  Although  this  setting  is  gen-
erally  designed  to  deal  with  occasional  airborne  infectious
diseases,  such  as  tuberculosis,  it  is  not  prepared  to  systemat-
ically  assess  high-risk  cases  that  need  additional  resources,
diminish  productivity  and  effectiveness  and  generate  a  huge
workload.
Thus,  each  IP  unit  must  rethink  their  administrative
and  logistic  circuits  in  different  areas,  as  well  as  the  type
and  timing  of  performed  procedures,  to  protect  both  HCW
and  patients.  Moreover,  as  international  health  associa-
tions  advocate,  an  infection-control  program  in  healthcare
settings  should  be  implemented,  consisting  of  a  three-
level  hierarchy,  including  administrative,  environmental  and
engineering  controls,  and  personal  protection  equipment
(PPE).16 In  the  following  subsections,  each  of  the  above
listed  hierachic  levels  are  briefly  presented.
Administrative  and  organizational  issues
Administrative  and  logistic  measures  are  crucial  to  ensur-
ing  safety  while  still  maintaining  IP  activity.17 Some  general
precautions  include:
-  All  referrals  and  requests  to  the  IP  unit  must  preferably
be  made  by  telephone  or  digital  means.Please  cite  this  article  in  press  as:  Guedes  F,  et  al.  Pulmonol.  2
-  Upon  schedule  and  24−48  h  prior  to  arrival  at  the  IP  Unit,
patients  should  be  contacted  by  telephone  and  submitted
to  a  pre-screening  checklist  that  includes  questions  about
1)  recent  symptoms  suggestive  of  COVID-19  (e.g.  fever,
-
 PRESS
19  outbreak  3
cough,  chills,  muscle  pain,  shortness  of  breath/difficulty
breathing,  headache,  sore  throat,  loss  of  taste  or  smell);
2)  contact  with  suspicious/confirmed  SARS-CoV-2  cases;
and  3)  occupational  exposure.
 Patients  who  have  recent  respiratory  and  infectious  symp-
toms  and/or  chest  imaging  suggestive  of  COVID-19,  should
have  their  elective  procedures  postponed  and  rescheduled
after  all  symptoms  are  resolved.
 On  arrival  at  the  IP  Unit,  all  patients  must  be  asked
again  for  respiratory  symptoms  and  have  their  temper-
ature  checked.
 If  possible,  all  patients  should  have  at  least  one  negative
RT-PCR  for  SARS-CoV-2  in  the  24−48  h preceding  the  exam.
In  patients  with  a  positive  RT-PCR  SARS-CoV-2,  the  deci-
sion  to  procede  with  the  intervention  will  be  based  on  the
urgency  of  the  procedure  (Chart  1  and  Table  1).
 The  IP  unit  should  keep  a  record  of  deferred  patients  to
reschedule  their  procedures  according  to  the  COVID-19
outbreak  situation,  as  proposed  in  Table  2.
nvironmental  and  engineering  control
hysical  space  preparation
he  design  of  strategies  to  minimize  risks  and  a  protocol
tting  the  characteristics  of  each  specific  Unit  are  crucial.18
 Reception,  administrative,  clinical  and  waiting  areas
should  separate  confirmed/high-risk  patients  from
negative/low-risk  ones.  In  addition,  inpatients  should  be
segregated  from  outpatients,  either  by  time  or  physical
location,  to  prevent  cross  infection.
 Specific  circuits  and  written  workflow  plans  must  be
prepared,  covering  the  pre-procedural  area,  procedural
room,  post-procedural  area,  decontamination  and  repro-
cessing.  The  implementation  of  a  flowchart  with  different
areas  and  walking  paths  using  a  visual  colour  zone  sys-
tem  can  be  useful:  1)  red  zone  for  contaminated  areas;
2)  yellow  zone  for  transition  areas,  and  3)  green  zone  for
non-COVID-19  safe  areas19 (Fig.  1A).  These  need  to  be  for-
mulated  by  internal  elements  from  the  IP  unit  with  the
cooperation  of  a multidisciplinary  team  of  hospital  mem-
bers,  including  administration,  engineers,  and  infection
control  board.
 A  specific  place  to  store  and  retrieve  all  items  required
for  PPE  should  be  defined  inside  the  Unit.
 A  designated  area  in  the  Unit  should  be  selected,  close  to
the  procedural  suite,  for  gowning  and  removal  of  all  PPE,
according  to  hospital  protocol  and  standards,  in  order  to
reduce  exposure  to  contaminated  particles  and  droplets.
When  an  anteroom  is  available,  it  may  be  used  as  an  area
for  donning  and  doffing  of  PPE  (Fig.  1B).
 Stations  should  be  created  to  facilitate  frequent  hand
hygiene  and  to  distribute  waste  containers  according  to
local  infectious  control  recommendations.  Posters  and
other  visual  aids  should  be  placed  at  strategic  locations
around  the  intervention  suite  to  act  as  reminders.PULMOE 1525 1--12020.  https://doi.org/10.1016/j.pulmoe.2020.07.007
 Emergency  procedures  in  COVID-19  positive  patients
should  preferably  be  performed  within  the  ICU  enviro-
ment,  with  controlled  airway  through  cuffed  endotracheal
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Chart  1  Proposed  triage  of  IP  procedures  during  the  COVID-19  outbreak.Q1
Table  1  Priorization  of  IP  exams  according  to  SARS-CoV-2  status  and  procedure  urgency.Q2
ARTICLE IN+ModelPULMOE 1525 1--12
Recommendations  for  interventional  pulmonology  during  COVID-
Table  2  Schedule  of  IP  procedures  according  to  the  stage
of COVID-19  pandemic.
COVID-19  in  the  community  IP  Unit
Exponential  increase  of  new
cases
Urgent  cases  --  only
Rapid  increase  of  new  cases Urgent  cases  -- only
Elective  but  not  delayable  --
evaluate  case-by-case
Decrease  in  new  cases  Urgent  cases  --  full  capacity
Elective,  but  not  delayable  --
full  capacity
Elective  and  delayable  --
resume  partial  capacity















































































305last 2  weeks capacity
-  Elective  procedures  should  be  reserved  for  COVID-19  neg-
ative  patients  (Chart  1  and  Table  1).  Nevertheless,  these
procedures  should  still  be  performed  in  a  dedicated  neg-
ative  pressure  room  (see  below,  ventilation  requirement)
with  strict  isolation  precautions  and  sufficient  ventilation
to  avoid  aerosol  contamination.20 If  these  requirements
are  not  met  in  the  bronchoscopy  suite,  then  in  a  different
venue,  such  as  an  operating  theatre,  isolation  room  or  the
ICU  with  negative  pressure,  if  available.
-  If  negative  pressure  rooms  are  unavailable  througout  the
instituition,  a  specific  and  dedicated  room  with  adequate
natural  ventilation  (see  requirement  below)  may  be  an
alternative,  provided  that  appropriate  intervals  between
procedures  are  reserved  and  that  the  suspected  COVID-19
cases  be  programmed  after  all  planned  non-COVID  daily
activity,  so  that  the  unit  can  be  carefully  cleaned  (follow-
ing  the  disinfection  policy)  and  ventilated.
-  Keep  the  endoscopy  room  for  procedures  only  (all  other
activities,  such  as  planning,  reporting  and  laboratory  req-
uisition  should  take  place  elsewhere).
-  Suspected  and  confirmed  cases  of  COVID-19  must  be
placed  in  an  airborne  infection  isolation  room  with  neg-Please  cite  this  article  in  press  as:  Guedes  F,  et  al.  Pulmonol.  2
ative  pressure  before  and  after  the  procedure.  Low-risk
and  negative  patients  can  remain  in  the  pre-procedural
and  recovery  area,  if  there  is  adequate  room  ventilation,
Figure  1  A.  Implementation  of  specific  circuits  with  colour  visual  zo
(2, yellow  zone)  and  safe  cleaned  areas  (3,  green  zone).  B.  Designate
visual aids  were  placed  strategically  to  act  as  reminders. PRESS
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protective  equipment  (e.g.  surgical  mask)  and  physical
distance  (>2  m)  from  other  negative  patients.
entilation
 Patient  source  control  strategies,  such  as  wearing  a  mask
should  be  encouraged.
 Whenever  feasible,  it  is  recommended  procedures  are
pereformed  in  a  room  that  meets  the  ventilation  require-
ments  for  Airborne  Infection  Isolation  (AII),  ensuring  the
dilution  and  removal  of  contaminated  air.  The  preferred
system  is  a  negative  pressure  room  with  at  least  12  air
changes  per  hour  (ACH)  with  airflow  direction  control
(single-pass  or  recirculation  systems  with  HEPA  filtration).
Alternatively,  natural  ventilation  with  an  airflow  of  at
least  160  L/s  is  an  option.19,21
 Enough  time  should  be  allowed  to  ensure  that  contam-
inated  air  is  removed  from  the  room  before  performing
another  procedure  in  the  same  room  (depending  on  ACH
and  disinfection  methods,  but  at  least  30  min).  Local
adaptations  must  be  considered  according  to  the  charac-
teristics  of  the  IP  unit.
leaning  and  disinfecting  patient  care  equipment  and
ooms
ndoscopes  are  considered  semi-critical  medical  instru-
ents  according  to  the  Spaulding  classification.22 Rec-
mmendations  from  the  Centers  for  Disease  Control
nd  Prevention  (CDC)  on  reprocessing  procedures  should
e  followed.  These  include  pre-cleaning,  leak-testing,
anual  cleaning  and  visual  inspection  followed  by  disinfec-
ion/sterilization.
 A  high-level  manual  disinfection  or  using  an  automated
endoscope  reprocessor  is  recommended.
 Proper  storage  and  documentation  are  also  an  integral
part  of  the  reprocessing  workflow.
 A  pathway  of  contaminated  equipment  must  be  defined,
as  well  as  adequate  packaging  to  minimize  exposure  (for
example,  a  hermetic  box).PULMOE 1525 1--12020.  https://doi.org/10.1016/j.pulmoe.2020.07.007
for  confirmed  COVID-19  patients  with  clear  advantages  in
portability,  post-procedural  handling  and  cross  contami-
nation  risk.23
ne  system  to  distinguish  contaminated  (1,  red  zone),  transition
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Table  3  Specifications  for  personal  protective  equipment  during  IP  procedures.
PPE  Characteristics/specifications/standards  Observations
Gloves  ©  Single-use
© Waterproof
© Standard  EN  ISO  374-2:2014,
374-3:2014  e  374.5:2016
© Double  gloves:
-  first:  long  sleeved  gloves
- second:  nitrile  gloves
Eye Protection  ©  Goggles  with  lateral
protection
If  not  for  single  use,  perform  disinfection  with
ethanol  base  solution  or  0.1%  sodium  hipochlorite
© Face  shield
Gowns  ©  Single-use  Consider  biological  risk  protection  EN  14126:2004,
if confirmed  positive  patient
© Waterproof
© Long  sleeved
© Standard  EN  14605:2009
Cap  ©  Single-use  Consider  hood  cap,  if  confirmed  positive  patient
Shoe cover  ©  Single-use
Respiratory  ©  FFP2/N95  Perform  seal  check  before  enter  the  endoscopy
suite.



















































































362PPE, personal protective equipment.
 Floors  and  surfaces  of  the  endoscopy  suite  must  be  disin-
fected  after  each  procedure.
 Intermediate  level  disinfectants  with  proven  activity
against  enveloped  viruses  include  0.1%  sodium  hipochlo-
rite,  62--71%  ethanol,  0.5%  hydrogen  peroxide  and
quaternary  ammonium  compounds.19,24,25
ersonal  protective  equipment
P  procedures  are  considered  to  be  consistently  subjected
o  the  highest  risk  of  exposure.  In  this  setting,  full  precau-
ions  must  be  taken  to  cover  all  different  possible  types
f  transmission  (contact,  droplet  and  airborne).26 Person-
el  involved  in  the  reprocessing  procedure  must  also  wear
rotective  equipment  consisting  of  eye  protection,  respira-
ory  mask  FP2,  long  sleeved  gown  and  double  gloves.27,28 The
ecommendations  for  the  use  of  PPE  are  shown  in  Table  3.
pecimen  transportation
amples  from  the  upper  and  lower  respiratory  tract,  includ-
ng  pleural  effusion,  are  deemed  to  be  the  most  potentially
nfectious.  Consequently,  they  should  be  handled  as  Cate-
ory  3 pathogen  and  double-bagged  (first  the  specimen  must
e  bagged  in  the  patient’s  room  and  then  taken  out  of  the
oom  and  placed  in  a  separate  pre-labeled  specimen  bag).
ll  specimens  must  be  manually  delivered.28,29Please  cite  this  article  in  press  as:  Guedes  F,  et  al.  Pulmonol.  2
afety rules for staff and patients
t  is  also  important  to  define  proper  new  rules  for  both  HCW
nd  patients  circulating  in  the  IP  unit,  as  listed  below:
-
ealth  professionals
 The  IP  Unit  should  reduce  and  prioritise  the  allocation  of
human  resources  according  to  the  outbreak  evolution  and
hospital  needs.  The  minimum  number  of  staff  required  to
ensure  a  correct  operation  must  be  clearly  defined.
 It  is  essential  that  all  personnel  follow,  train  and  maintain
competency  in  effective  hand  hygiene  and  every  aspect  of
PPE  (theoretical,  training  and  simulation  sessions)  so  that
everyone  is  familiar  with  their  role.
 All  interactions  with  patients,  including  informed  con-
sent,  should  be  done  with  appropriate  PPE  and  frequent
hand  washing.  The  staff  should  not  reduce  the  level  of
awareness  and  protection,  and  the  idea  that  patients  with
suspected  COVID-19  should  be  handled  in  the  same  manner
as  confirmed  cases  must  be  reinforced.
 A  core  team  that  includes  only  essential  HCW  should
perform  the  procedure  on  SARS-CoV-2  positive  patients.
The  most  experienced  staff  should  be  responsible  for  the
exam  to  reduce  time  and  deal  effectively  with  possible
complications.  Other  healthcare  personnel,  such  as  resi-
dents,  medical  students  and  visitors  should  not  be  inside
the  unit  and  the  examination  room  before,  during  or  after
the  procedure.
 Of  note,  the  scheduled  exams  must  be  done  during  normal
working  hours  (avoiding  an  emergency  basis  or  setting)
and  in  an  appropriate,  designated  room  that  fulfils  all  the
standards  required  for  care.
atients  and  other  personelPULMOE 1525 1--12020.  https://doi.org/10.1016/j.pulmoe.2020.07.007
 Respiratory  and  contact  isolation  should  be  standard  and
mandatory  for  all  patients.  Outpatients  and  inpatients









































































































































Recommendations  for  interventional  pulmonology  during  CO
and  keep  it  on  at  all  times  (until  the  beginning  and  after
the  end  of  the  procedure)  to  minimize  the  risk  of  trans-
mission.  No  unnecessary  personal  items  should  be  brought
into  the  IP  unit.
-  Family  members  and  caregivers  should  not  stay  in  the  IP
waiting  rooms.  In  case  of  children  or  patients  in  need  of
support,  the  Unit  can  allow  a  single  relative  to  enter  the
preparation  area  to  provide  aid.
- The  entry  into  the  Unit  of  suppliers  and  medical  devices
sales  representatives  must  be  restricted.
Prioritization of procedures
Scheduled  elective  procedures  should  be  reviewed  and  can-
celled  if  potentially  delayable,  until  local  control  of  the
outbreak  is  achieved.  After  flattening  the  infectious  curve,
many  elective  IP  procedures  will  have  to  be  performed,  as
they  are  essential  to  provide  a  definitive  diagnosis  and  effec-
tive  treatment.  At  this  time,  it  is  advisable  to  evaluate  the
delayed  requests  and  to  optimize  the  procedure  planning
based  on  clinical  needs  and  operational  capability.
A  suggested  rational  approach  for  stratification  of  pro-
cedures  is  provided  in  Table  1,  but  we  recognize  that,  in
certain  cases,  the  indication  may  not  be  straightforward,
and  the  risk-benefit  must  be  weighted  on  an  individual  basis
by  the  IP  team.31 Although  rescheduling  certain  procedures
is  obvious  in  other  cases  it  may  not  be  desirable  or  eth-
ical.  It  is  important  to  note  that  these  indications  may
change  according  to  local  epidemiological  conditions  and
the  response  capabilities  of  the  healthcare  system.  Several
societies  have  recommended  different  levels  of  procedure
stratification.26,30,31 Briefly,  what  is  recommended  is  a step-
wise  reopening  of  elective  IP  procedures  according  to  the
national  and  local  COVID-19  outbreak  situation,  depending
on  the  number  of  new  confirmed  cases,  hospital  admitted
cases  (ward  and  ICU),  availability  of  equipment  and  health-
care  staff,  time  elapse  and  number  of  postponed  IP  cases.
Some  authors34 have  proposed  a  summary  of  the  elective
endoscopic  procedure  by  phases,  as  shown  in  Table  2.  Any-
way,  it  should  be  noted  that  the  evolving  procedural  criteria
should  always  be  communicated  to  other  physicians  who
refer  patients  for  invasive  respiratory  procedures  and  to  the
hospital  administration.
Recommendations for bronchoscopy
Bronchoscopy  under  spontaneous  ventilation
The  following  reccomendations  are  expert  opinion-based
and  should  be  adapted  to  local  regulations  and  guidelines.
In  an  optimal  scenario,  it  is  safer  to  perform  elective
bronchoscopy  under  general  anesthesia  and  orotracheal
intubation,  clinical  conditions  permitting.  If  this  is  not  pos-
sible,  bronchoscopy  can  be  performed  under  spontaneous
ventilation.  Some  recommendations  are  listed  below:Please  cite  this  article  in  press  as:  Guedes  F,  et  al.  Pulmonol.  2
-  Operator  should  be  standing  behind  the  patient’s  head  to
reduce  direct  exposure.  Oxygen  supplementation  should
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a  nasal  cannula  or  preferably  with  an  oxygen  mask  with
an  entrance  to  the  bronchoscope  (Fig.  2A).
 For  flexible  bronchoscopy,  a  transnasal  approach  should  be
preferred,  and  a  surgical  mask  should  be  placed  over  the
patient’s  mouth  to  minimize  droplet  emission  (Fig.  2B).
 In  hypoxemic  patients,  bronchoscopy  can  be  performed
under  NIV,  using  a  closed  circuit  ventilation  (double  cir-
cuit  with  viral  filters  in  both  arms)  and  non-ventilated
masks  with  a  dedicated  bronchoscope  entrance  (Fig.  2C).
High  performance  NIV  ventilators  with  FiO2 regulation  are
preferable.  From  the  end  of  the  procedure,  NIV  should  be
continued  for  1−2  h,  titrating  the  FiO2 to  obtain  an  SpO2
of  around  94--95%.
 Bronchoscopy  under  nasal  high-flow  oxygen  therapy  is  not
reccomended  and  thus  should  be  avoided.
 Nebulized  medications  should  be  avoided  before  or  after
the  procedure.
 Proper  sedation  should  be  used  to  minimize  cough  reflex
and  to  increase  patient  cooperation.
 An  oral  aspiration  cannula  should  be  available  during  the
procedure  (Fig.  2B).
 A  transparent  protective  box  may  enhance  safety  by  con-
taining  dispersal  of  droplet  particles  (Fig.  2D).  The  box  is
placed  over  the  patient’s  head  prior  to  bronchoscopy,  with
the  anesthesia  equipment  already  in  place.  The  broncho-
scope  is  inserted  through  the  covered  opening  behind  the
patient  (Fig.  2E).
ronchoscopy  in  the  intubated  patient
he  following  recommendations  are  directed  for  patients
nder  mechanical  ventilation  in  an  ICU  setting  due  to
espiratory  failure.  As  reported,  5%  of  COVID-19  patients
an  develop  respiratory  failure  and  will  need  ventilatory
upport32; moreover,  associated  bacterial,  viral  and  fun-
al  co-infection  should  not  be  negleted.33 In  critically  ill
atients  under  invasive  ventilation,  ventilator-associated
neumonia  occurs  in  up  to  30%  and  lobar  collapse  is  fre-
uent  and  multifactorial.34 The  same  adaptations  apply  to
lective  procedures  under  general  anesthesia,  performed  in
he  Bronchoscopy  Unit  or  Operating  Theatre.
 A  cuffed  endotracheal  tube  is  preferred  over  supraglotic
devices,  such  as  a  laryngeal  mask;  cuff  pressure  should  be
maintained  between  25--30  cmH2O.35
 General  anesthesia  with  muscle  relaxant  is  recommended
to  reduce  the  aerosol  production.
 FiO2 should  be  adjusted  to  100%.
 Volume  control,  pressure-limited  mode  is  preferable  and
PEEP  should  be  kept  at  the  same  level  during  the  proce-
dure.  Adjustments  can  be  made  dynamically,  with  a  prior
assessment  of  the  anticipated  risks  (e.g.,  lung  derecruit-
ment  and  desaturation,  arrhythmias,  pneumothorax).
 To  avoid  aerosol  dispersion,  a simple  and  appropriate
maneuver  consists  of  clamping  the  ventilation  circuit  just
before  introduction  of  bronchoscope,  repeating  the  same
step  just  before  withdrawal.PULMOE 1525 1--12020.  https://doi.org/10.1016/j.pulmoe.2020.07.007
 Bronchoscope  removal  and  reinsertion  should  be  avoided
during  the  procedure.
 In  hypoxemic  patients,  if  bronchoalveolar  lavage  is  needed
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Figure  2  Strategies  to  minimize  droplets  dispersal  during  bronchoscopy.  A.  The  bronchoscope  may  be  introduced  through  an
opening made  at  the  oxygen  mask,  in  this  case  with  an  additional  plastic  sheet  covering  the  patient’s  head.  B.  Transnasal  approach,
with oxygen  supplementation  through  nasal  cannula  and  a  surgical  mask  placed  over  the  patient’s  mouth  and  the  oral  aspiration
canulla. C.  Bronchoscopy  can  be  performed  under  ventilatory  support,  using  a  closed  circuit  ventilation  and  non-ventilated  masks
with a  dedicated  bronchoscope  entrance.  D.  Transparent  protective  box  may  contain  droplet  particles  inside.  E.  Protective  box






























































509laced over  the  patient’s  head  during  endobronchial  ultrasound
nd a  plastic  covering.
reduced  to  a  minimum.  If  a  SARS-Cov-2  diagnosis  is
needed,  a  minimum  of  2−3  mL  of  recovered  lavage  is
enough.26
igid  bronchoscopy
igid  bronchoscopy  is  used  for  diagnostic  and  therapeu-
ic  purposes,  in  procedures  where  flexible  bronchoscopy
ould  be  deemed  difficult  or  even  impossible,  like  obtain-
ng  larger  samples  of  endobronchial  lesions,  foreign  body
emoval,  management  of  central  airway  obstruction  (includ-
ng  ablative  techniques,  like  electrocautery,  argon  plasma
oagulation,  laser,  cryotherapy,  among  others,  and  place-
ent  of  airway  stents)  or  massive  hemoptysis.36
There  are  different  ventilation  strategies  used  duringPlease  cite  this  article  in  press  as:  Guedes  F,  et  al.  Pulmonol.  2
igid  bronchoscopy,  although  manual  jet  ventilation  and  high
requency  jet  ventilation  are  much  the  most  frequent.37
ommon  to  these  two  techniques  is  the  fact  that  the  prox-
mal  end  of  the  bronchoscope  is  open  to  allow  the  passage
t
N
Rigid  bronchoscopy  with  rubber  caps  on  the  ports  of  the  scope
f  instruments,  thus  ventilation  is  achieved  providing  100%
xygen  under  high  pressure  (usually  50  psi)  through  an  open
ystem.39,40 The  use  of  these  ventilation  techniques  means
hat  aerosols  are  released  into  the  room,  making  it  a  high-
isk  procedure.
In  patients  with  suspected  or  confirmed  COVID-19  diag-
osis,  rigid  bronchoscopy  should  be  avoided,  except  for
rgent  cases  (Table  1).  Clinical  scenarios  are  mostly
herapeutic,  like  acute  foreign  body  aspiration,  massive
emoptysis  (when  there  is  no  place  for  embolization),
evere  symptomatic  central  airway  obstruction  (either
enign  or  malignant)  and  migrated  stents.  In  a  clinically
table  patient,  upon  suspicion  of  foreign  body  aspiration,
ne  should  consider  non-contrast  computerized  tomography
CT)  to  confirm  the  presence  of  a  foreign  body  before  rigid
ronchoscopy,  to  avoid  unnecessary  exams.38,39PULMOE 1525 1--12020.  https://doi.org/10.1016/j.pulmoe.2020.07.007
In  some  centers,  the  rigid  scope  is  used  to  perform  other
echniques,  like  Endobronchial  Ultrasound-Transbronchial










































































































































Recommendations  for  interventional  pulmonology  during  CO
obiopsy;  this  provides  comfort  to  the  operator  and  safety  in
case  of  major  bleeding.  The  authors  recommend  perform-
ing  these  diagnostic  procedures  through  cuffed  endotracheal
tube  to  minimize  the  risk  of  exposure.  However,  the  operator
must  be  ready  to  convert  to  rigid  bronchoscopy,  if  necessary.
In  a  patient  undergoing  rigid  bronchoscopy,  it  is  recom-
mended  that:
-  Rigid  bronchoscopy  should  always  be  performed  in  a  neg-
ative  pressure  room.
-  Controlled  ventilation  is  preferred,  with  the  rigid  bron-
choscope  used  like  an  endotracheal  tube.
-  Air  leaks  should  be  reduced  using  rubber  caps  on  the
ports  of  the  rigid  scope,  as  well  as  using  a  plastic  cover-
ing  (Fig.  2F)  or  filling  the  mouth  with  gauze.40 While  this
strategy  is  more  appealing  to  minimize  aerosol  spread,
the  operator  may  find  it  challenging  to  handle  instruments
through  the  working  channel.
Recommendations for pleural techniques
Pleural  effusion  does  not  appear  to  be  a  prominent  feature
of  COVID-19.  It  occurs  in  5.3--5.8%  of  patients,  according  to
two  recent  meta-analyses.41,42 There  have  been  occasional
reports  of  bilateral  effusion  that  resolved  spontaneously.43
As  bacterial  superinfection  is  common  in  severe  patients,
they  can  also  develop  complicated  effusions  or  empyema,
requiring  targeted  treatment.  There  have  been  a  few
anecdotal  reports  of  spontaneous  pneumothorax  and  pneu-
momediastinum  in  severe  COVID-19  pneumonia,  requiring
drainage.44,45 This  may  be  more  frequent  in  critical  patients
on  invasive  ventilation,  which  can  lead  to  bronchopleural
fistulae.46 It  is,  therefore,  plausible  that  pleural  drainage
may  be  necessary  in  some  COVID-19  patients,  either  in  the
ICU  or  in  the  ward,  and  indications  for  drainage  do  not
differ  from  the  standard  clinical  guidelines.  However,  as
with  any  invasive  procedure  in  confirmed  COVID-19  patients,
all  precautions  regarding  the  full  use  of  protective  equip-
ment  should  be  taken.  The  procedure  must  be  performed
by  trained  and  dedicated  staff  to  reduce  its  duration  and
to  minimize  the  risk  of  complications.  In  other  situations,
the  use  of  ultrasound  may  be  very  helpful  with  COVID-
19  patients.47 Besides  its  wide  availability,  safety  and  low
cost,  it  is  easy  to  use  at  the  bedside  and  allows  medical
staff  to  detect  small  pleural  effusions  and  to  guide  pleural
fluid  collection  and  drainage,  if  needed.  On  the  other  hand,
even  patients  without  suspected  COVID-19  can  have  assymp-
tomatic  infection;  so,  any  procedure  should  be  considered  as
a  possible  COVID-19  case  and  precautions  should  be  taken.
Indeed,  although  some  procedures  may  be  postponed,  in
many  situations  they  should  not  be  deferred,  especially  in
suspected  or  confirmed  cancer  patients.  It  is  crucial  that
cancer  patients  do  not  experience  delays  in  diagnostic  or
therapeutic  procedures  due  to  the  present  contingency.48
Few  societies  have  published  guidelines  addressing  pleu-
ral  procedures  during  COVID-19  pandemic.  The  BritishPlease  cite  this  article  in  press  as:  Guedes  F,  et  al.  Pulmonol.  2
Thoracic  Society  has  issued  guidance  on  pleural  ser-
vices  provision,49 mainly  to  minimize  hospital  visits  and
admissions  and  to  ensure  both  patient  and  staff  safety.
Nonetheless,  although  we  recognize  lack  of  published  evi-
-
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ence  supporting  these  reccomendations,  this  document
ill  adopt  some  of  them.
First  of  all,  despite  pleural  procedures  not  being  listed
s  Aerosol  Generating  Procedure  (AGP)  in  the  CDC  updated
eccomendations,50 they  should  be  considered  so  and  Level
 PPE  should  be  worn,  as  described  above.  Other  societies
ave  considered  potential  AGP  as  any  procedure  ‘‘likely
o  induce  coughing,  that  should  be  performed  cautiously
nd  avoided  if  possible’’.51 This  is  particularly  relevant  to
pen  procedures,  such  as  thoracoscopy  and  indwelling  pleu-
al  catheter  insertion,  and  in  case  of  pneumothorax  with
uspected  bronchial-pleural  fistula.  Thus,  we  recommend
aking  the  following  precautions:
leural  effusion
 On  suspicion  of  malignant  effusion,  diagnostic  pleural  fluid
aspiration  should  be  performed,  especially  if  the  patient
is  a  candidate  for  systemic  therapy  or  if  the  effusion  is
symptomatic  (Table  1).
 Consider  placement  of  indwelling  pleural  catheters  for
recurrent  malignant  pleural  effusions,  avoiding  repeated
hospital  drainage  or  admission.
 On  suspicion  of  pleural  infection,  pleural  fluid  aspiration
and  analysis  should  be  performed.
 In  case  of  benign  pleural  effusions,  the  risk-benefit  should
be  discussed  with  the  attending  physician;  procedures  can
be  postponed  if  the  patient  is  not  symptomatic.
 Thoracoscopy  is  not  recommended  as  a  principle;  how-
ever,  in  the  absence  of  alternative  options,  its  risk-benefit
must  be  assessed.
neumothorax
 Spontaneous  primary  pneumothorax  can  be  managed  in
outpatient  care  if  the  risk  assessment  allows  and  if  there
is  local  team  experience;  needle  aspiration  and  discharge
should  be  considered  if  the  patient  is  minimally  symp-
tomatic.
 When  pleural  drainage  placement  is  necessary,  if  there  is
local  expertise  and  the  patient  is  at  low  risk,  the  use  of
pleural  vent  systems  should  be  considered,  thus  allowing
the  patient  to  be  managed  at  home.
hest  drainage  placement  and  care
 Extra  care  must  be  taken  when  placing  the  chest  tubes,  in
order  to  avoid  open  communication  with  the  pleural  space
and  the  potentialemission  of  droplets  and  aerossols.
 When  chest  tubes  are  placed  in  ventilated  patients,  con-
sideration  should  be  given  to  clamping  the  ventilator
circuit  before  assessing  the  pleural  cavity,  so  that  positive
pressure  spreading  of  pleural  air  or  fluid  can  be  prevented.
 Whenever  possible,  the  use  of  non-wired  pleural  drainage
should  be  considered;  it  can  be  connected  to  the  drainage
system  before  insertion  into  the  pleural  cavity  (closed  cir-PULMOE 1525 1--12020.  https://doi.org/10.1016/j.pulmoe.2020.07.007
cuit).
 When  pleuroscopy  is  required,  the  use  of  one  way  valve
trocars  should  be  preferred  to  assess  the  pleural  cavity
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679 In  case  of  prolonged  air-leaks,  the  use  of  wall  suction
should  be  weighted  to  create  a  closed  system.
oncluding remarks
s  with  other  societal  consensus  papers,  this  document
as  developed  by  a  restricted  panel  of  experts  from
he  Portuguese  Society  of  Pulmonology;  individual  clini-
al  judgment  and  local  resources  may  lead  to  alternative
erspectives.  This  guidance  was  based  on  the  current  knowl-
dge  of  COVID-19,  but,  as  new  data  appears,  this  statement
hould  be  revised  in  the  future  to  accommodate  updated
ecommendations.  At  present,  one  of  the  controversial
ssumptions  is  that,  every  patient,  even  if  asymptomatic,
hould  be  assumed  as  potentially  infected  with  SARS-CoV-
.  Therefore,  it  is  mandatory  that  contact  precautions  and
roper  training  on  donning  and  doffing  of  PPE  be  provided
o  all  HCWs  involved  in  IP.  Another  key  element  is  to  plan
n  advance  and  keep  each  IP  Unit  well-organized  (Table  4).
lthough  the  reduction  in  the  number  of  elective  procedures
epresents  one  of  the  central  strategies  to  improve  safety,
t  is  crucial  that  patients  do  not  suffer  unnecessary  delays  in
iagnostic  or  therapeutic  procedures  due  to  the  current  con-
ingency.  Taken  together,  our  ultimate  intention  is  to  bring
ull  attention  to  this  and  future  outbreaks  or  other  emerging
edical  situations.Please  cite  this  article  in  press  as:  Guedes  F,  et  al.  Pulmonol.  2
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